Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) is maternal inheritance, or mitochondrial inheritance, caused by mutations in mitochondrial DNA11778, 14484 or 3460.It's a common type of inherited optic neuropathy. Related drugs include oxygen, ribonucleic acid, arginine, aidibenzoquinone, vitamin C, unoprostol.
This report contains market size and forecasts of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) in global, including the following market information:
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) companies in 2021 (%)
The global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dominant Optic Atrophy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) include Alkeus Pharmaceuticals, Amgen, Biovista, Editas Medicine, GenSight Biologics, Ixchel Pharma, Khondrion, Mitotech and ProQR Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment Percentages, by Type, 2021 (%)
Dominant Optic Atrophy
Recessive Optic Atrophy
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment Percentages, by Application, 2021 (%)
Hospitals
Eye Clinics
Medical Research Institute
Other
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) revenues share in global market, 2021 (%)
Key companies Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Leber’s Hereditary Optic Neuropathy (LHON) (Leber Optic Atrophy) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alkeus Pharmaceuticals
Amgen
Biovista
Editas Medicine
GenSight Biologics
Ixchel Pharma
Khondrion
Mitotech
ProQR Therapeutics
Sanofi
Spark Therapeutics
Stealth BioTherapeutics
Usher Syndrome